Axxcess Wealth Management LLC Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Axxcess Wealth Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,554 shares of the medical equipment provider’s stock after acquiring an additional 2,003 shares during the period. Axxcess Wealth Management LLC’s holdings in Intuitive Surgical were worth $5,585,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth approximately $26,000. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. LGT Financial Advisors LLC boosted its holdings in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the period. Delos Wealth Advisors LLC grew its stake in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in Intuitive Surgical during the 1st quarter worth about $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 1,413 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $438.60, for a total value of $619,741.80. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,414,931.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 1,413 shares of the business’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,414,931.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,120 shares of company stock worth $25,528,753. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on ISRG shares. Morgan Stanley raised their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. Barclays boosted their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Finally, Evercore ISI dropped their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a report on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Intuitive Surgical Trading Up 0.3 %

Intuitive Surgical stock opened at $491.39 on Tuesday. The stock has a market capitalization of $174.30 billion, a price-to-earnings ratio of 88.70, a PEG ratio of 5.41 and a beta of 1.39. The stock has a 50 day moving average of $464.67 and a two-hundred day moving average of $422.79. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $496.18.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period last year, the company earned $1.18 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.